RT @accpcritprn: Adding to the biomarker debate: A Biomarker-based strategy to de-escalate empiric antifungal treatment showed a LARGE impr…
Adding to the biomarker debate: A Biomarker-based strategy to de-escalate empiric antifungal treatment showed a LARGE improvement (54% v. 2%) in early discontinuation with no difference in outcomes compared to routine care. https://t.co/k3hzwQFIXe #Crit
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
RT @TAEscmid: In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical…
In this RCT, use of biomarkers ((1,3)-β-d-glucan, mannan &anti-mannan) increased the early discontinuation rates of empirical #antifungal Rx among patients with suspected invasive #Candida infection, with no negative impact on the outcome. #ThematicWee
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @Fluid_Academy: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of... https://t.co/TzDqakECI2 by #matthewjr…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
#LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of... https://t.co/TzDqakECI2 by #matthewjrowland https://t.co/yhJEkyaUWT
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
Insuficiencia de corticoides relacionado a la enfermedad crítica #LIVES2017 https://t.co/kfTHLrrjC0
Biomarcadores séricos permiten suspender de manera segura los antimicóticos #LIVE2017 https://t.co/kfTHLrrjC0 https://t.co/MJD5V0eHnx
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
RT @yourICM: #LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5k…
#LIVES2017 Just released in ICM!Biomarker-based strategy for discontinuation of empirical antifungal treatment https://t.co/5knSaZyrZ7 https://t.co/xdefUAoM5S